Gene therapy used to combat immunodeficiency

c x

UCLA researchers are using a gene therapy to restore the immune systems of children with so-called “Bubble Boy” disease. The Ainslie family has been dealing with a rare disease since their son was born. Mom Jessica Ainslie says, “He started getting really bad cough, vomiting, and throwing up.”

Colton, 5, has severe combined immunodeficiency or SCID, also known as “Bubble Boy Disease. He’s missing a gene needed for his immune system to develop. Kids with the condition are extremely vulnerable to viruses and bacteria and can die within one to two years if not treated it’s a fatal disease.

View the original article here: Gene therapy used to combat immunodeficiency – Today’s THV

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
Farmers can talk to plants
Farmers are a major source of misinformation—about farming
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
a ufo a photoblog
U.S. government accused of pushing ‘fake news’ about UFOs to cover-up secret dark-project drone and aircraft technology
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.